Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Assessment of competence in video-assisted thoracoscopic surgery lobectomy: A Danish nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Short- and long-term cause of death in patients undergoing isolated coronary artery bypass grafting: A nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Rarity of invasiveness in right-sided infective endocarditis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Coronary artery disease is associated with an increased mortality rate following video-assisted thoracoscopic lobectomy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Incidence of Ischemic Stroke in Individuals With and Without Aortic Valve Stenosis: A Danish Retrospective Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiovascular complications in patients with total cavopulmonary connection: A nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: Oral anticoagulation with vitamin K antagonists is recommended after mechanical heart valve replacement. However, data regarding the association between the quality of vitamin K antagonist treatment and the risk of complications are sparse.

METHODS: Patients undergoing mechanical heart valve replacement (1997-2012) with available data on international normalized ratio values were identified in Danish registries. The quality of vitamin K antagonist treatment between discharge after valve replacement and 6 months postdischarge (ie, index) was assessed as time in therapeutic range (TTR) ≥70% or <70% reflecting the percentage of time in therapeutic international normalized ratio interval. Patients were followed from index until occurrence of an outcome of interest (ie, thromboembolism and bleeding), death, or end of study (December 31, 2012), whichever came first. The risk of outcomes according to quality of vitamin K antagonist treatment was estimated with multivariable Cox regression.

RESULTS: In total, 659 patients undergoing mechanical heart valve replacement were included in the study. Median number of international normalized ratio measurements in the 6-month period after surgery was 13 (interquartile range, 8-19). Median TTR was 54.9% (interquartile range, 39.0%-72.9%) and 29.1% of patients had a TTR ≥70%. Median follow-up was 6.1 years. The risk of thromboembolism was significantly lower in the group with TTR ≥70% compared with TTR <70% (hazard ratio, 0.44; 95% confidence interval, 0.22-0.85), whereas no significant difference concerning risk of bleeding among groups was found (hazard ratio, 0.63; 95% confidence interval 0.36-1.08).

CONCLUSIONS: In patients undergoing mechanical heart valve replacement, TTR <70% in the 6-month period after surgery was associated with an increased risk of thromboembolic events but not bleeding compared with TTR ≥70%.

Original languageEnglish
JournalJournal of Thoracic and Cardiovascular Surgery
Volume159
Issue number1
Pages (from-to)74-83.e4
ISSN0022-5223
DOIs
Publication statusPublished - 1 Jan 2020

    Research areas

  • epidemiology, mechanical heart valve prostheses, Nordic Medico-Statistical Committee, oral anticoagulation, time in therapeutic range, vitamin K antagonists

ID: 58229759